Necthreonin A
| Internal ID | d0061fc2-320f-4674-a2c5-056519cb2b2a |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | (2S)-1-[2-[[(2S,3S)-2-[[(2S)-2-[[2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]-N-[(2S)-1-[[(2S)-1-[[2-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-hydroxy-4-methylpentan-2-yl]amino]-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-2-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide |
| SMILES (Canonical) | CCC(C)C(C(=O)NC(C)(C)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(C)(CC)C(=O)NCC(=O)NC(C(C)O)C(=O)NC(CC(C)C)CO)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C |
| SMILES (Isomeric) | CC[C@H](C)[C@@H](C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@](C)(CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)CO)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)C |
| InChI | InChI=1S/C53H95N11O13/c1-18-31(9)40(60-42(69)32(10)55-48(75)51(13,14)61-43(70)36(24-29(5)6)56-34(12)67)47(74)62-52(15,16)50(77)64-22-20-21-38(64)45(72)58-37(25-30(7)8)44(71)63-53(17,19-2)49(76)54-26-39(68)59-41(33(11)66)46(73)57-35(27-65)23-28(3)4/h28-33,35-38,40-41,65-66H,18-27H2,1-17H3,(H,54,76)(H,55,75)(H,56,67)(H,57,73)(H,58,72)(H,59,68)(H,60,69)(H,61,70)(H,62,74)(H,63,71)/t31-,32-,33+,35-,36-,37-,38-,40-,41-,53-/m0/s1 |
| InChI Key | OUYPVHQJZQZJSV-SJEQYAIMSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C53H95N11O13 |
| Molecular Weight | 1094.40 g/mol |
| Exact Mass | 1093.71108213 g/mol |
| Topological Polar Surface Area (TPSA) | 352.00 Ų |
| XlogP | 2.40 |
| Atomic LogP (AlogP) | -0.33 |
| H-Bond Acceptor | 13 |
| H-Bond Donor | 12 |
| Rotatable Bonds | 31 |
| RefChem:164970 |
| (2S)-1-(2-(((2S,3S)-2-(((2S)-2-((2-(((2S)-2-acetamido-4-methylpentanoyl)amino)-2-methylpropanoyl)amino)propanoyl)amino)-3-methylpentanoyl)amino)-2-methylpropanoyl)-N-((2S)-1-(((2S)-1-((2-(((2S,3R)-3-hydroxy-1-(((2S)-1-hydroxy-4-methylpentan-2-yl)amino)-1-oxobutan-2-yl)amino)-2-oxoethyl)amino)-2-methyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide |
| (2S)-1-[2-[[(2S,3S)-2-[[(2S)-2-[[2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]-N-[(2S)-1-[[(2S)-1-[[2-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-hydroxy-4-methylpentan-2-yl]amino]-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-2-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide |
| (2S)-N-((1S)-1-(((((1S,2R)-2-hydroxy-1-(((2S)-1-hydroxy-4-methylpentan-2-yl)-C-hydroxycarbonimidoyl)propyl)-C-hydroxycarbonimidoyl)methyl)-C-hydroxycarbonimidoyl)-1-methylpropyl)-2-((hydroxy((2S)-1-(2-(((2S,3S)-1-hydroxy-2-(((2S)-1-hydroxy-2-((1-hydroxy-2-(((2S)-1-hydroxy-2-((1-hydroxyethylidene)amino)-4-methylpentylidene)amino)-2-methylpropylidene)amino)propylidene)amino)-3-methylpentylidene)amino)-2-methylpropanoyl)pyrrolidin-2-yl)methylidene)amino)-4-methylpentanimidate |
| (2S)-N-[(1S)-1-[({[(1S,2R)-2-hydroxy-1-{[(2S)-1-hydroxy-4-methylpentan-2-yl]-C-hydroxycarbonimidoyl}propyl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]-1-methylpropyl]-2-({hydroxy[(2S)-1-(2-{[(2S,3S)-1-hydroxy-2-{[(2S)-1-hydroxy-2-[(1-hydroxy-2-{[(2S)-1-hydroxy-2-[(1-hydroxyethylidene)amino]-4-methylpentylidene]amino}-2-methylpropylidene)amino]propylidene]amino}-3-methylpentylidene]amino}-2-methylpropanoyl)pyrrolidin-2-yl]methylidene}amino)-4-methylpentanimidate |
| CHEBI:215091 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7044 | 70.44% |
| Caco-2 | - | 0.8591 | 85.91% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.6286 | 62.86% |
| Subcellular localzation | Mitochondria | 0.5045 | 50.45% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8514 | 85.14% |
| OATP1B3 inhibitior | + | 0.9214 | 92.14% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 1.0000 | 100.00% |
| BSEP inhibitior | + | 0.9456 | 94.56% |
| P-glycoprotein inhibitior | + | 0.7425 | 74.25% |
| P-glycoprotein substrate | + | 0.8550 | 85.50% |
| CYP3A4 substrate | + | 0.7290 | 72.90% |
| CYP2C9 substrate | - | 0.7982 | 79.82% |
| CYP2D6 substrate | - | 0.8357 | 83.57% |
| CYP3A4 inhibition | - | 0.7980 | 79.80% |
| CYP2C9 inhibition | - | 0.8917 | 89.17% |
| CYP2C19 inhibition | - | 0.8000 | 80.00% |
| CYP2D6 inhibition | - | 0.8901 | 89.01% |
| CYP1A2 inhibition | - | 0.9193 | 91.93% |
| CYP2C8 inhibition | + | 0.5784 | 57.84% |
| CYP inhibitory promiscuity | - | 0.9307 | 93.07% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | - | 0.7900 | 79.00% |
| Carcinogenicity (trinary) | Non-required | 0.6186 | 61.86% |
| Eye corrosion | - | 0.9845 | 98.45% |
| Eye irritation | - | 0.8973 | 89.73% |
| Skin irritation | - | 0.7882 | 78.82% |
| Skin corrosion | - | 0.9000 | 90.00% |
| Ames mutagenesis | - | 0.6800 | 68.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3820 | 38.20% |
| Micronuclear | + | 0.6500 | 65.00% |
| Hepatotoxicity | + | 0.5907 | 59.07% |
| skin sensitisation | - | 0.8802 | 88.02% |
| Respiratory toxicity | + | 0.7444 | 74.44% |
| Reproductive toxicity | + | 0.7556 | 75.56% |
| Mitochondrial toxicity | + | 0.7250 | 72.50% |
| Nephrotoxicity | + | 0.4810 | 48.10% |
| Acute Oral Toxicity (c) | III | 0.6426 | 64.26% |
| Estrogen receptor binding | + | 0.7138 | 71.38% |
| Androgen receptor binding | + | 0.7095 | 70.95% |
| Thyroid receptor binding | + | 0.5802 | 58.02% |
| Glucocorticoid receptor binding | + | 0.6478 | 64.78% |
| Aromatase binding | + | 0.7089 | 70.89% |
| PPAR gamma | + | 0.7725 | 77.25% |
| Honey bee toxicity | - | 0.7725 | 77.25% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6800 | 68.00% |
| Fish aquatic toxicity | - | 0.6071 | 60.71% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.92% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.04% | 96.61% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.73% | 98.94% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.61% | 97.25% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 98.28% | 95.00% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 98.07% | 89.63% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 97.89% | 94.45% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.87% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.57% | 96.09% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.24% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.12% | 93.56% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 95.52% | 99.77% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 95.44% | 100.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 95.36% | 97.50% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 95.29% | 97.14% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.20% | 94.66% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.02% | 98.10% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 94.63% | 95.71% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 94.50% | 92.12% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 94.14% | 98.89% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 93.62% | 97.29% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 93.55% | 91.19% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 93.08% | 97.43% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 93.02% | 96.47% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.52% | 100.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 92.41% | 96.67% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 92.09% | 86.67% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 91.61% | 96.31% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 91.18% | 95.52% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 90.49% | 94.00% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 90.20% | 97.47% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 90.19% | 96.67% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 89.88% | 95.38% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 89.58% | 97.09% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 89.02% | 96.03% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 88.94% | 88.42% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 88.90% | 96.00% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 88.84% | 95.36% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 88.78% | 96.90% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 88.70% | 93.04% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 88.03% | 97.64% |
| CHEMBL4801 | P29466 | Caspase-1 | 87.99% | 96.85% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 87.15% | 100.00% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.13% | 94.33% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 87.09% | 93.33% |
| CHEMBL3691 | Q13822 | Autotaxin | 86.94% | 96.39% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 86.92% | 96.67% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 86.83% | 90.93% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 86.70% | 97.50% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 86.56% | 97.29% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 86.37% | 93.10% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 86.24% | 97.23% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 86.22% | 92.80% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 85.82% | 83.14% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 85.80% | 81.29% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 85.68% | 90.08% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 85.14% | 98.59% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 85.14% | 96.95% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 85.13% | 98.05% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 84.69% | 98.75% |
| CHEMBL3055 | P50613 | Cyclin-dependent kinase 7 | 84.64% | 81.88% |
| CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 84.33% | 94.36% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 83.88% | 89.33% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 83.69% | 96.33% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 83.39% | 97.21% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 83.37% | 96.37% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 83.30% | 82.38% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 83.18% | 98.57% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.58% | 90.24% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 82.39% | 98.24% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 81.87% | 92.88% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 81.86% | 97.64% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 81.85% | 90.71% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 81.49% | 97.56% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 81.29% | 92.38% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 80.93% | 95.83% |
| CHEMBL236 | P41143 | Delta opioid receptor | 80.65% | 99.35% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 80.62% | 95.89% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 80.50% | 95.17% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 80.45% | 90.17% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 80.20% | 82.05% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139590861 |
| LOTUS | LTS0242907 |
| wikiData | Q105200548 |